Ibis Sánchez-Serrano

Core Model Corp., Panama City, Panama

Abstract:

The high price of medicines, the ongoing productivity crisis at the bio-pharmaceutical industry level, and the current world’s health care crisis, underline the need for more efficient approaches to bring drugs to the market.  Here, the “Core Model”—a novel organizational paradigm for research and development (R & D)—is described to demonstrate the powerful potential of effective translational science and academia/industry- public/private collaboration in discovering and developing new drugs. The implementation of the Core Model, in a systematic manner, and the creation of relevant public policy initiatives fostering translational science and more academia-industry collaborations could have a tremendous positive impact in solving some of the most important pharmaceutical and health care problems worldwide.